Roles of cancer registries in enhancing oncology drug access in the asia-pacific region

Swee Sung Soon, Hwee Yong Lim, Gilberto Lopes, Jeonghoon Ahn, Min Hu, Hishamshah Mohd Ibrahim, Anand Jha, Bor Sheng Ko, Pak Wai Lee, Diana MacDonell, Ekaphop Sirachainan, Hwee Lin Wee

Research output: Contribution to journalArticle

Abstract

Cancer registries help to establish and maintain cancer incidence reporting system, serve as a resource for investigation of cancer and its causes, and provide information for planning and evaluation of preventive and control programs. However, their wider role in directly enhancing oncology drug access has not been fully explored. We examined the value of cancer registries in oncology drug access in the Asia-Pacific region on three levels: (1) specific registry variable types; (2) macroscopic strategies on the national level; and (3) a regional cancer registry network. Using literature search and proceedings from an expert forum, this paper covers recent cancer registry developments in eight economies in the Asia-Pacific region - Australia, China, Hong Kong, Malaysia, Singapore, South Korea, Taiwan, and Thailand - and the ways they can contribute to oncology drug access. Specific registry variables relating to demographics, tumor characteristics, initial treatment plans, prognostic markers, risk factors, and mortality help to anticipate drug needs, identify high-priority research area and design access programs. On a national level, linking registry data with clinical, drug safety, financial, or drug utilization databases allows analyses of associations between utilization and outcomes. Concurrent efforts should also be channeled into developing and implementing data integrity and stewardship policies, and providing clear avenues to make data available. Less mature registry systems can employ modeling techniques and ad-hoc surveys while increasing coverage. Beyond local settings, a cancer registry network for the Asia-Pacific region would offer cross-learning and research opportunities that can exert leverage through the experiences and capabilities of a highly diverse region.

Original languageEnglish (US)
Pages (from-to)2159-2165
Number of pages7
JournalAsian Pacific Journal of Cancer Prevention
Volume14
Issue number4
DOIs
StatePublished - 2013

Fingerprint

Registries
Pharmaceutical Preparations
Neoplasms
Preventive Health Services
Pharmaceutical Databases
Drug Utilization
Republic of Korea
Malaysia
Singapore
Hong Kong
Thailand
Taiwan
China
Research Design
Demography
Learning
Safety
Mortality
Incidence
Research

Keywords

  • Asia
  • Cancer
  • Drug access
  • Oncology
  • Pacific region
  • Registry

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Roles of cancer registries in enhancing oncology drug access in the asia-pacific region. / Soon, Swee Sung; Lim, Hwee Yong; Lopes, Gilberto; Ahn, Jeonghoon; Hu, Min; Ibrahim, Hishamshah Mohd; Jha, Anand; Ko, Bor Sheng; Lee, Pak Wai; MacDonell, Diana; Sirachainan, Ekaphop; Wee, Hwee Lin.

In: Asian Pacific Journal of Cancer Prevention, Vol. 14, No. 4, 2013, p. 2159-2165.

Research output: Contribution to journalArticle

Soon, SS, Lim, HY, Lopes, G, Ahn, J, Hu, M, Ibrahim, HM, Jha, A, Ko, BS, Lee, PW, MacDonell, D, Sirachainan, E & Wee, HL 2013, 'Roles of cancer registries in enhancing oncology drug access in the asia-pacific region', Asian Pacific Journal of Cancer Prevention, vol. 14, no. 4, pp. 2159-2165. https://doi.org/10.7314/APJCP.2013.14.4.2159
Soon, Swee Sung ; Lim, Hwee Yong ; Lopes, Gilberto ; Ahn, Jeonghoon ; Hu, Min ; Ibrahim, Hishamshah Mohd ; Jha, Anand ; Ko, Bor Sheng ; Lee, Pak Wai ; MacDonell, Diana ; Sirachainan, Ekaphop ; Wee, Hwee Lin. / Roles of cancer registries in enhancing oncology drug access in the asia-pacific region. In: Asian Pacific Journal of Cancer Prevention. 2013 ; Vol. 14, No. 4. pp. 2159-2165.
@article{59a15f35d6bb46838c161703d477a0ca,
title = "Roles of cancer registries in enhancing oncology drug access in the asia-pacific region",
abstract = "Cancer registries help to establish and maintain cancer incidence reporting system, serve as a resource for investigation of cancer and its causes, and provide information for planning and evaluation of preventive and control programs. However, their wider role in directly enhancing oncology drug access has not been fully explored. We examined the value of cancer registries in oncology drug access in the Asia-Pacific region on three levels: (1) specific registry variable types; (2) macroscopic strategies on the national level; and (3) a regional cancer registry network. Using literature search and proceedings from an expert forum, this paper covers recent cancer registry developments in eight economies in the Asia-Pacific region - Australia, China, Hong Kong, Malaysia, Singapore, South Korea, Taiwan, and Thailand - and the ways they can contribute to oncology drug access. Specific registry variables relating to demographics, tumor characteristics, initial treatment plans, prognostic markers, risk factors, and mortality help to anticipate drug needs, identify high-priority research area and design access programs. On a national level, linking registry data with clinical, drug safety, financial, or drug utilization databases allows analyses of associations between utilization and outcomes. Concurrent efforts should also be channeled into developing and implementing data integrity and stewardship policies, and providing clear avenues to make data available. Less mature registry systems can employ modeling techniques and ad-hoc surveys while increasing coverage. Beyond local settings, a cancer registry network for the Asia-Pacific region would offer cross-learning and research opportunities that can exert leverage through the experiences and capabilities of a highly diverse region.",
keywords = "Asia, Cancer, Drug access, Oncology, Pacific region, Registry",
author = "Soon, {Swee Sung} and Lim, {Hwee Yong} and Gilberto Lopes and Jeonghoon Ahn and Min Hu and Ibrahim, {Hishamshah Mohd} and Anand Jha and Ko, {Bor Sheng} and Lee, {Pak Wai} and Diana MacDonell and Ekaphop Sirachainan and Wee, {Hwee Lin}",
year = "2013",
doi = "10.7314/APJCP.2013.14.4.2159",
language = "English (US)",
volume = "14",
pages = "2159--2165",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "4",

}

TY - JOUR

T1 - Roles of cancer registries in enhancing oncology drug access in the asia-pacific region

AU - Soon, Swee Sung

AU - Lim, Hwee Yong

AU - Lopes, Gilberto

AU - Ahn, Jeonghoon

AU - Hu, Min

AU - Ibrahim, Hishamshah Mohd

AU - Jha, Anand

AU - Ko, Bor Sheng

AU - Lee, Pak Wai

AU - MacDonell, Diana

AU - Sirachainan, Ekaphop

AU - Wee, Hwee Lin

PY - 2013

Y1 - 2013

N2 - Cancer registries help to establish and maintain cancer incidence reporting system, serve as a resource for investigation of cancer and its causes, and provide information for planning and evaluation of preventive and control programs. However, their wider role in directly enhancing oncology drug access has not been fully explored. We examined the value of cancer registries in oncology drug access in the Asia-Pacific region on three levels: (1) specific registry variable types; (2) macroscopic strategies on the national level; and (3) a regional cancer registry network. Using literature search and proceedings from an expert forum, this paper covers recent cancer registry developments in eight economies in the Asia-Pacific region - Australia, China, Hong Kong, Malaysia, Singapore, South Korea, Taiwan, and Thailand - and the ways they can contribute to oncology drug access. Specific registry variables relating to demographics, tumor characteristics, initial treatment plans, prognostic markers, risk factors, and mortality help to anticipate drug needs, identify high-priority research area and design access programs. On a national level, linking registry data with clinical, drug safety, financial, or drug utilization databases allows analyses of associations between utilization and outcomes. Concurrent efforts should also be channeled into developing and implementing data integrity and stewardship policies, and providing clear avenues to make data available. Less mature registry systems can employ modeling techniques and ad-hoc surveys while increasing coverage. Beyond local settings, a cancer registry network for the Asia-Pacific region would offer cross-learning and research opportunities that can exert leverage through the experiences and capabilities of a highly diverse region.

AB - Cancer registries help to establish and maintain cancer incidence reporting system, serve as a resource for investigation of cancer and its causes, and provide information for planning and evaluation of preventive and control programs. However, their wider role in directly enhancing oncology drug access has not been fully explored. We examined the value of cancer registries in oncology drug access in the Asia-Pacific region on three levels: (1) specific registry variable types; (2) macroscopic strategies on the national level; and (3) a regional cancer registry network. Using literature search and proceedings from an expert forum, this paper covers recent cancer registry developments in eight economies in the Asia-Pacific region - Australia, China, Hong Kong, Malaysia, Singapore, South Korea, Taiwan, and Thailand - and the ways they can contribute to oncology drug access. Specific registry variables relating to demographics, tumor characteristics, initial treatment plans, prognostic markers, risk factors, and mortality help to anticipate drug needs, identify high-priority research area and design access programs. On a national level, linking registry data with clinical, drug safety, financial, or drug utilization databases allows analyses of associations between utilization and outcomes. Concurrent efforts should also be channeled into developing and implementing data integrity and stewardship policies, and providing clear avenues to make data available. Less mature registry systems can employ modeling techniques and ad-hoc surveys while increasing coverage. Beyond local settings, a cancer registry network for the Asia-Pacific region would offer cross-learning and research opportunities that can exert leverage through the experiences and capabilities of a highly diverse region.

KW - Asia

KW - Cancer

KW - Drug access

KW - Oncology

KW - Pacific region

KW - Registry

UR - http://www.scopus.com/inward/record.url?scp=84880281642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880281642&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2013.14.4.2159

DO - 10.7314/APJCP.2013.14.4.2159

M3 - Article

C2 - 23725106

AN - SCOPUS:84880281642

VL - 14

SP - 2159

EP - 2165

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 4

ER -